参考文献/References:
[1]Jokinen E. Obesity and cardiovascular disease[J]. Minerva Pediatr,2015,67(1):25-32.
[2]Wang S,Lei T,Zhang K,et al. Xenobiotic pregnane X receptor (PXR) regulates innate immunity via activation of NLRP3 inflammasome in vascular endothelial cells[J]. J Biol Chem,2014,289(43):30075-30081.
[3]Oladimeji PO,Chen T. PXR:more than just a master xenobiotic receptor[J]. Mol Pharmacol,2018,93(2):119-127.
[4]Chai SC,Wright WC,Chen T. Strategies for developing pregnane X receptor antagonists:implications from metabolism to cancer[J]. Med Res Rev,2020,40(3):1061-1083.
[5]Swales KE,Moore R,Truss NJ,et al. Pregnane X receptor regulates drug metabolism and transport in the vasculature and protects from oxidative stress[J]. Cardiovasc Res,2012,93(4):674-681.
[6]Wang X,Fang X,Zhou J,et al. Shear stress activation of nuclear receptor PXR in endothelial detoxification[J]. Proc Natl Acad Sci U S A,2013,110(32):13174-13179.
[7]Banerjee M,Robbins D,Chen T. Targeting xenobiotic receptors PXR and CAR in human diseases[J]. Drug Discov Today,2015,20(5):618-628.
[8]孙小淋,鲁敏,楚英杰. 巨噬细胞的异质性与动脉粥样硬化[J]. 中华心血管病杂志,2019，47(8):660-663.
[9]Zhou J,Zhai Y,Mu Y,et al. A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway[J]. J Biol Chem,2006,281(21):15013-15020.
[10]Zhou C,King N,Chen KY,et al. Activation of PXR induces hypercholesterolemia in wild-type and accelerates atherosclerosis in ApoE deficient mice[J]. J Lipid Res,2009,50(10):2004-2013.
[11]Tian K,Xu Y,Sahebkar A,et al. CD36 in atherosclerosis:pathophysiological mechanisms and therapeutic implications[J]. Curr Atheroscler Rep,2020,22(10):59.
[12]Sui Y,Xu J,Rios-Pilier J,et al. Deficiency of PXR decreases atherosclerosis in apoE-deficient mice[J]. J Lipid Res,2011,52(9):1652-1659.
[13]Sui Y,Meng Z,Park SH,et al. Myeloid-specific deficiency of pregnane X receptor decreases atherosclerosis in LDL receptor-deficient mice[J]. J Lipid Res,2020,61(5):696-706.
[14]Meng Z,Gwag T,Sui Y,et al. The atypical antipsychotic quetiapine induces hyperlipidemia by activating intestinal PXR signaling[J]. JCI Insight,2019,4(3):e125657.
[15]Gwag T,Meng Z,Sui Y,et al. Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis[J]. J Hepatol,2019,70(5):930-940.
[16]Karpale M,K?r?j?m?ki AJ,Kummu O,et al. Activation of pregnane X receptor induces atherogenic lipids and PCSK9 by a SREBP2-mediated mechanism[J]. Br J Pharmacol,2021,178(12):2461-2481.
[17]Sui Y,Meng Z,Chen J,et al. Effects of dicyclohexyl phthalate exposure on PXR activation and lipid homeostasis in mice[J]. Environ Health Perspect,2021,129(12):127001.
[18]Sui Y,Park SH,Helsley RN,et al. Bisphenol A increases atherosclerosis in pregnane X receptor-humanized ApoE deficient mice[J]. J Am Heart Assoc,2014,3(2):e000492.
[19]Sui Y,Park SH,Wang F,et al. Perinatal bisphenol A exposure increases atherosclerosis in adult male PXR-humanized mice[J]. Endocrinology,2018,159(4):1595-1608.
[20]Wu Y,Yu H,Tang HQ,et al. PXR polymorphisms have impact on the clinical efficacy of clopidogrel in patients undergoing percutaneous coronary intervention[J]. Gene,2018,653:22-28.
[21]Yang W,Yu Z,Chiyoya M,et al. Menaquinone-4 accelerates calcification of human aortic valve interstitial cells in high-phosphate medium through PXR[J]. J Pharmacol Exp Ther,2020,372(3):277-284.
[22]Zhao LY,Xu JY,Shi Z,et al. Pregnane X receptor (PXR) deficiency improves high fat diet-induced obesity via induction of fibroblast growth factor 15 (FGF15) expression[J]. Biochem Pharmacol,2017,142:194-203.
[23]Nakamura K,Moore R,Negishi M,et al. Nuclear pregnane X receptor cross-talk with FoxA2 to mediate drug-induced regulation of lipid metabolism in fasting mouse liver[J]. J Biol Chem,2007,282(13):9768-9776.
相似文献/References:
[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(6):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[3]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(6):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[4]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(6):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[5]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(6):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[6]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(6):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[7]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[8]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(6):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[9]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(6):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[10]韦莹 刘书旺 李蕾 崔鸣.生长分化因子-15在心房颤动中的研究进展[J].心血管病学进展,2019,(8):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]
WEI Ying,LIU Shuwang,LI Lei,et al.Growth Differentiation Factor-15 in Development of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(6):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]